297 related articles for article (PubMed ID: 32161444)
21. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.
Fernandez HH; Vanagunas A; Odin P; Espay AJ; Hauser RA; Standaert DG; Chatamra K; Benesh J; Pritchett Y; Hass SL; Lenz RA
Parkinsonism Relat Disord; 2013 Mar; 19(3):339-45. PubMed ID: 23287001
[TBL] [Abstract][Full Text] [Related]
22. Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.
Othman AA; Rosebraugh M; Chatamra K; Locke C; Dutta S
J Parkinsons Dis; 2017; 7(2):275-278. PubMed ID: 28211816
[TBL] [Abstract][Full Text] [Related]
23. Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE.
Aldred J; Anca-Herschkovitsch M; Antonini A; Bajenaru O; Bergmann L; Bourgeois P; Cubo E; Davis TL; Iansek R; Kovács N; Kukreja P; Onuk K; Pontieri FE; Robieson W; Siddiqui MS; Simu M; Standaert DG; Chaudhuri KR
Neurodegener Dis Manag; 2020 Oct; 10(5):309-323. PubMed ID: 32873195
[No Abstract] [Full Text] [Related]
24. Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease.
Fabbri M; Pongmala C; Artusi CA; Romagnolo A; Rizzone MG; Zibetti M; Lopiano L
Acta Neurol Scand; 2019 Aug; 140(2):157-161. PubMed ID: 31025312
[TBL] [Abstract][Full Text] [Related]
25. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
[TBL] [Abstract][Full Text] [Related]
26. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.
Willows T; Dizdar N; Nyholm D; Widner H; Grenholm P; Schmiauke U; Urbom A; Groth K; Larsson J; Permert J; Kjellander S
J Parkinsons Dis; 2017; 7(4):719-728. PubMed ID: 28984615
[TBL] [Abstract][Full Text] [Related]
27. Levodopa-Carbidopa Intestinal Gel Injection for Patient with Severe Parkinson's Disease Followed by Total Hip Arthroplasty: A Case Report and Literature Review.
Imamura A; Kuroyanagi G; Usami T; Sato T; Horiba M; Sakai H; Takahashi A; Ueki Y; Matsukawa N; Murakami H
Orthop Surg; 2023 Nov; 15(11):2993-2999. PubMed ID: 37712322
[TBL] [Abstract][Full Text] [Related]
28. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
Antonini A; Yegin A; Preda C; Bergmann L; Poewe W;
Parkinsonism Relat Disord; 2015 Mar; 21(3):231-5. PubMed ID: 25585993
[TBL] [Abstract][Full Text] [Related]
29. Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation.
Regidor I; Santos-García D; Catalán MIJ; Puente V; Valldeoriola F; Grandas F; Mir P; Parra JC; Arbelo JM
J Parkinsons Dis; 2019; 9(1):173-182. PubMed ID: 30562907
[TBL] [Abstract][Full Text] [Related]
30. Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience.
Bohlega S; Abou Al-Shaar H; Alkhairallah T; Al-Ajlan F; Hasan N; Alkahtani K
Eur Neurol; 2015; 74(5-6):227-36. PubMed ID: 26618531
[TBL] [Abstract][Full Text] [Related]
31. A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK.
Lowin J; Bergman A; Chaudhuri KR; Findley LJ; Roeder C; Schifflers M; Wood E; Morris S
J Med Econ; 2011; 14(5):584-93. PubMed ID: 21728911
[TBL] [Abstract][Full Text] [Related]
32. Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial.
Freire-Alvarez E; Kurča E; Lopez Manzanares L; Pekkonen E; Spanaki C; Vanni P; Liu Y; Sánchez-Soliño O; Barbato LM
Mov Disord; 2021 Nov; 36(11):2615-2623. PubMed ID: 34236101
[TBL] [Abstract][Full Text] [Related]
33. Advanced therapies in Parkinson's disease: Long-term retrospective study.
Merola A; Espay AJ; Romagnolo A; Bernardini A; Rizzi L; Rosso M; Espay KJ; Zibetti M; Lanotte M; Lopiano L
Parkinsonism Relat Disord; 2016 Aug; 29():104-8. PubMed ID: 27215392
[TBL] [Abstract][Full Text] [Related]
34. [Levodopa-carbidopa intestinal gel in the treatment of patients with Parkinson disease: results of a 12-month open study].
Skoromets AA; Odinak MM; Yakupov EZ; Litvinenko IV; Zalyalova ZA; Timofeeva AA; Kirtaev SY; Bogdanov RR; Agafina AS; Chatamra K; Robieson W; Benesh J; Latypova GR; Ershova MV; Illarioshkin SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):22-31. PubMed ID: 28374689
[TBL] [Abstract][Full Text] [Related]
35. The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England.
Chaudhuri KR; Pickard AS; Alobaidi A; Jalundhwala YJ; Kandukuri PL; Bao Y; Sus J; Jones G; Ridley C; Oddsdottir J; Najle-Rahim S; Madin-Warburton M; Xu W; Schrag A
Pharmacoeconomics; 2022 May; 40(5):559-574. PubMed ID: 35307793
[TBL] [Abstract][Full Text] [Related]
36. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
[TBL] [Abstract][Full Text] [Related]
37. An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients.
Krüger R; Lingor P; Doskas T; Henselmans JML; Danielsen EH; de Fabregues O; Stefani A; Sensken SC; Parra JC; Onuk K; Yegin A; Antonini A
Adv Ther; 2017 Jul; 34(7):1741-1752. PubMed ID: 28631218
[TBL] [Abstract][Full Text] [Related]
38. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
[TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.
Valldeoriola F; Grandas F; Santos-García D; Regidor I; Catalán MJ; Arbelo JM; Puente V; Mir P; Parra JC
Neurodegener Dis Manag; 2016 Aug; 6(4):289-98. PubMed ID: 27440190
[TBL] [Abstract][Full Text] [Related]
40. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
